Project IN-DEPTH Study

Overview

Project IN-DEPTH is a five-year joint research initiative between the U.S. Department of Veterans Affairs (VA) and the National Institutes of Health (NIH), announced in April 2023, aimed at applying new research methods to explain the chronic symptoms of Gulf War Illness.

Key Facts

| Aspect | Details |
|--------|---------|
| Announcement Date | April 2023 |
| Duration | Five years |
| Lead Organizations | VA and NIH |
| Study Director | Dr. Michelle Costanzo, Director of Research at Washington D.C. WRIISC |
| Screening Locations | Miami VA Medical Center; Palo Alto WRIISC (California); Washington D.C. WRIISC |
| Testing Duration | Two weeks per participant |

Gulf War Illness Background

Gulf War Illness affects approximately one-third of the nearly 700,000 men and women who served in Southwest Asia during Operations Desert Shield and Desert Storm (1990-1991). The disease is characterized by:

Fatigue
Headache
Memory difficulties
Joint and muscle pain
Poor sleep
Breathing problems
Digestive issues

VA refers to the condition as a "medically unexplained illness" due to its wide symptom variability.

Study Methodology: Deep Phenotyping

The study employs deep phenotyping — an innovative approach that examines how different parts of the body function and interact with one another to precisely describe the underlying factors of the disease. This method allows researchers to:

Describe illness through multi-system analysis
Identify patterns across physiological systems
Develop more precise diagnostic criteria

Veteran Engagement

The study team employed Gulf War Veteran advisors throughout planning, shaping the approach to ensure clinical relevance for enrolled Veterans.

Community Response: More than 400 Veterans contacted the study team after news of the partnership was released — far exceeding expectations. Responses included:

Volunteering for participation

Expressing hope for future treatment options

Voicing frustration over past treatment experiences

Data Repository and Follow-up Care

A data repository will be established to allow other researchers to analyze protected information compiled through the study
Data sources include: Department of Defense records, VA medical records, and objective exposure data
All Veterans who complete the study receive a primary care follow-up visit
Priority recruitment targets Gulf War Veterans whose documented symptoms began during or close to their deployment

Related Research Initiatives

| Initiative | Focus |
|------------|-------|
| Million Veteran Program (MVP) | Largest cohort of Gulf War Veterans with research on self-report surveys, medical records, and genetic information in relation to Gulf War Illness |
| Gulf War Registry | Health exam program for Gulf War veterans |
| Research Advisory Committee on Gulf War Veterans' Illnesses (RAC-GWVI) | Scientific meetings, Veteran listening sessions, research alerts |

Benefits Context: PACT Act

Prior to 2022, VA considered six health conditions "presumptive" for Gulf War Illness — meaning qualifying Veterans did not have to prove a connection between military service and illness. These included myalgic encephalomyelitis/chronic fatigue syndrome, fibromyalgia, functional gastrointestinal disorders, and undiagnosed illnesses.

The SFC Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act (PACT Act) expanded benefits and eligibility periods for toxic exposures. VA has added more than 20 toxic exposure presumptive conditions based on the PACT Act, expanding benefits for Gulf War-era Veterans. All Veterans enrolled in VA health care receive an initial toxic exposure assessment with follow-up screening every five years.

Contact Information

Email: vhawas.indepth@va.gov
Website: "Who can enroll?" webpage (VA)
Clinical Trials: ClinicalTrials.gov — search by keyword "Gulf War" or "Gulf War Illness"

---